Table: Stella Pharma -2020/21 parent results

Stella Pharma

10/05/2021 07:20

May 10 (Reuters)- 
          Stella Pharma Corporation 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2021    Mar 31, 2020    Mar 31, 2022      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          205 mln                         223 mln                 
                                               (+8.3 pct)                
  Operating   loss 680 mln    loss 951 mln    loss 761 mln               
  Recurring   loss 656 mln    loss 959 mln    loss 773 mln               
  Net         loss 659 mln    loss 962 mln    loss 777 mln               
  EPS        loss 32.90 yen  loss 61.68 yen  loss 27.68 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T